无缝合主动脉瓣置换术与经导管主动脉瓣植入术的系统综述与Meta分析
该系统综述与Meta分析检索2000年1月至2016年10月多个数据库,纳入7项观察性研究共617例无缝合主动脉瓣置换术(SU-AVR)与621例经导管主动脉瓣植入术(TAVI)患者,比较早期死亡率、瓣周漏、早期卒中、出血事件及起搏器植入需求。结果显示SU-AVR早期死亡率低于TAVI,瓣周漏发生率TAVI更高,卒中与起搏器植入两组相当。
要点
- SU-AVR组早期死亡率为2.5%,TAVI组为5%(OR 0.52,95%CI 0.30-0.90,p=0.02,I²=2%)。
- SU-AVR术后显著瓣周漏发生率低于TAVI(OR 0.18,95%CI 0.11-0.30,p<0.0001)。
- 术后卒中与起搏器植入需求两组相当(OR 0.71与0.884,均未达统计学显著)。
核心结论
- 该观察性研究的Meta分析表明,在选定患者中SU-AVR术后早期死亡率低于TAVI,TAVI术后瓣周漏发生率更高,而卒中与起搏器植入率两种术式相当。
研究设计与样本
- 系统综述与Meta分析,检索多个数据库(2000年1月至2016年10月),纳入7项比较SU-AVR与TAVI临床结局的观察性研究,共617例SU-AVR患者与621例TAVI患者,采用随机效应逆方差加权分析,效应量以OR及95%CI表示。
主要发现
- 早期死亡率SU-AVR组为2.5%,TAVI组为5%(OR 0.52,95%CI 0.30-0.90,p=0.02,I²=2%)。
- 术后显著瓣周漏SU-AVR组低于TAVI组(OR 0.18,95%CI 0.11-0.30,p<0.0001)。
- 术后卒中两组相当(OR 0.71,95%CI 0.24-2.08,p=0.53)。
- 起搏器植入需求两组相当(OR 0.884,95%CI 0.364-2.18,p=0.7)。
关键数值与推荐
- 早期死亡率:SU-AVR组2.5% vs TAVI组5%,OR 0.52(95%CI 0.30-0.90,p=0.02,I²=2%)。
- 术后显著瓣周漏:SU-AVR组低于TAVI组,OR 0.18(95%CI 0.11-0.30,p<0.0001)。
- 术后卒中:OR 0.71(95%CI 0.24-2.08,p=0.53),两组相当。
- 起搏器植入需求:OR 0.884(95%CI 0.364-2.18,p=0.7),两组相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sutureless aortic valve replacement (SU-AVR) and transcatheter aortic valve implantation (TAVI) are increasingly adopted methods to treat high-risk patients with severe aortic valve stenosis. We conducted a systematic review and meta-analysis to compare the clinical outcomes between these two recent methods to treat aortic valve disease. METHODS: We systematically searched multiple databases (January 2000 to October 2016) to identify original studies comparing clinical outcome between SU-AVR and TAVI. End points studied were early mortality, development of paravalvular leak, early stroke, bleeding events, and the need for pacemaker insertion. A random-effect inverse-variance weighted analysis was performed. Event rates were compared as odds ratio (OR) and 95% confidence interval (CI). RESULTS: The meta-analysis included seven observational studies comprising 617 SU-AVR and 621 TAVI patients. Early mortality was 2.5% and 5% in the SU-AVR and TAVI cohorts, respectively (OR, 0.52; 95% CI, 0.30 to 0.90; p = 0.02; I2 = 2%). Postprocedural significant paravalvular leak was much lower after SU-AVR (OR, 0.18l; 95% CI, 0.11 to 0.30; p < 0.0001). Postprocedural stroke (OR, 0.71; 95% CI, 0.24 to 2.08; p = 0.53) and the need for pacemaker insertion (OR, 0.884; 95% CI, 0.364 to 2.18; p = 0.7) were comparable between the two cohorts. CONCLUSIONS: Our meta-analysis of observational studies demonstrates that early mortality is lower after SU-AVR than after TAVI in selected patients. The rates of stroke and pacemaker implant are comparable between procedures; however, the incidence of paravalvular leak is higher after TAVI.
引用
- Shinn SH, Altarabsheh SE, Deo SV, et al. A Systemic Review and Meta-Analysis of Sutureless Aortic Valve Replacement Versus Transcatheter Aortic Valve Implantation. Ann Thorac Surg. 2018. PMID: 29709503. doi:10.1016/j.athoracsur.2018.03.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。